Related Experiment Video
Updated: Jul 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Human chronic fascioliasis: hepatitis B and C among infected cases
A G Farghaly1, H N el-Morshedy, S A Sharaf
1Tropical Health Department, High Institute of Public Health.
Insights
This study found no significant liver enzyme changes in chronic Fasciola infections. However, hepatitis B virus (HBV) and hepatitis C virus (HCV) markers were more prevalent in older individuals.
Area of Science:
- Hepatology
- Infectious Diseases
- Parasitology
Background:
- Chronic Fasciola infection can affect liver health.
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant public health concerns.
- Co-infections or concurrent conditions require investigation.
Purpose of the Study:
- To investigate the prevalence of hepatitis B and C markers in chronic Fasciola cases.
- To assess the impact of these viral markers on liver function tests in the study population.
- To explore familial aggregation of hepatitis markers.
Main Methods:
- Screening of sera from 153 chronic Fasciola cases for hepatitis B surface antigen (HBsAg), anti-hepatitis B core (anti-HBc), anti-hepatitis B surface (anti-HBs), and anti-hepatitis C virus (anti-HCV) using ELISA.
- Quantitative stool examination.
- Estimation of liver enzymes (AST, ALT, bilirubin).
Main Results:
- Prevalence rates: HBsAg (3.3%), anti-HBs (8.5%), hepatitis B exposed (HBex) (28.8%), and anti-HCV (8.5%).
- HBV and HCV markers were significantly higher in older age groups.
- No significant changes were observed in Fasciola egg counts or liver function tests.
Conclusions:
- Chronic Fasciola infection did not significantly alter liver function tests or Fasciola egg counts.
- A notable prevalence of HBV and HCV markers exists within the chronic Fasciola patient group, particularly in older individuals.
- Familial aggregation of HBV exposure was observed in a subset of HBex cases.
Abstract:
Sera from one hundred and fifty three chronic Fasciola cases were screened for the presence of HB markers (HBsAg, anti HBc and anti HBs) and anti HCV using ELISA technique. Quantitative stool examination and estimation of liver enzymes (AST-ALT-bilirubin) levels of the study population were performed. HBsAg was present in 5 (3.3%), anti HBs in 13 (8.5%), HBexposed (HBex) in 44 (28.8%) and anti HCV in 13 (8.5%) of examined sera. HBV and HCV markers were significantly higher among older age groups. Concerning familial aggregation of hepatitis markers, 7 (15.9%) of the 44 HBex cases had two individuals per family who had evidence of exposure to HBV. No significant change in Fasciola GMEC and liver function tests have been noticed.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Amebiasis
Leishmaniasis
Toxoplasmosis
American Trypanosomiasis
